Abstract:Background: Asthma is a major health problem worldwide. Antiasthma drugs have side effects and can be expensive. It is important to develop antiasthma drugs from medicinal plants that have fewer side effects and are cheaper. One of the medicinal plants used for antiasthma treatment comes from Curcuma aeruginosa (Zingiberaceae family). The aim of the research is to examine spasmolytic activity of ethanol extract of C. aeruginosa on isolated guinea pig tracheas to determine the antiasthma effects. Methods: The s… Show more
COVID-19 (coronavirus disease) is an infectious disease of the respiratory tract caused by SARS-CoV-2.
Nature has provided a great source of antiviral compounds, from which innovative products for the
treatment of COVID-19 can be produced. One of the medicinal plants that can be developed for the
treatment of COVID-19 is Curcuma aeruginosa Roxb. Previous studies have found tracheospasmolytic
and anti-inflammatory activity of this indigenous Curcuma species. There are 10 chemical compounds
from Curcuma aeruginosa that have been proven against COVID-19, namely 1,8-cineole (eucalyptol),
α-terpineol, β-caryophyllene, β-eudesmol, β-pinene, β-sitosterol, curcumenol, palmitic acid, succinic
acid and zingiberene. Further research is needed for C. aeruginosa to become a new antiviral drug for
the treatment of COVID-19.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.